Journal of Reproduction and Development, Vol. 58, No 3, 2012

—Review—

Regulatory Pathways Controlling the Endovascular Invasive Trophoblast
Cell Lineage
Michael J. Soares1), Damayanti Chakraborty1), Stephen J. Renaud1), Kaiyu Kubota1),
Pengli Bu1), Toshihiro Konno1)# and M.A. Karim Rumi1)
1) Institute

for Reproductive Health and Regenerative Medicine, Department of Pathology and Laboratory Medicine,
University of Kansas Medical Center, Kansas 66160, USA
# Present: Laboratory of Animal Breeding, Graduate School of Agricultural and Life Science, University of Tokyo,
Tokyo 113-8657, Japan

Abstract. Hemochorial placentation is characterized by trophoblast-directed uterine spiral artery remodeling. The rat
and human both possess hemochorial placentation and exhibit remarkable similarities regarding the depth of trophoblast
invasion and the extent of uterine vascular modification. In vitro and in vivo research methodologies have been established
using the rat as an animal model to investigate the extravillous/invasive trophoblast lineage. With these research
approaches, two signaling pathways controlling the differentiation and invasion of the trophoblast cell lineage have been
identified: i) hypoxia/hypoxia inducible factor and ii) phosphatidylinositol 3-kinase/AKT/Fos like antigen 1. Dissection
of these pathways has facilitated identification of fundamental regulators of the invasive trophoblast cell lineage.
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T

he maternal-fetal interface is a dynamic site where uterine
and placental structures cooperate to promote development of
the fetus. The rat, mouse, and human each possess a hemochorial
placenta [1–3]. This type of placentation is characterized by erosion
of the maternal uterine epithelium and vasculature permitting the
direct flow of maternal nutrients to trophoblast cells. In species
exhibiting hemochorial placentation, remodeling of the uterine
vasculature is critical for the success of pregnancy [4–8]. As gestation progresses, uterine spiral arteries supplying the placenta are
modified creating flaccid, low resistance blood vessels [7–11]. These
vessels are the conduit required to meet the nutrient demands of the
fetus. Central to uterine spiral artery remodeling is a specialized
population of trophoblast cells referred to as invasive trophoblast
or alternatively, in humans, as extravillous trophoblast [5, 7, 9, 11].
Defective hemochorial placentation, including impairments in uterine spiral artery remodeling, leads to pregnancy related disorders
(preeclampsia, intrauterine growth restriction, preterm birth) that
cause significant morbidity and mortality for both mother and fetus
[4–7]. In addition, in utero insults have fundamental organizational
effects on the developing fetus, which affect postnatal health and
susceptibility to adult disease [12, 13].
The barrier for progress in understanding the invasive trophoblast cell lineage is the availability of appropriate experimental
models. Scientific approaches using cell culture systems and animal models that permit molecular dissection of mechanisms are
required. Our focus is on pathways that control cell differentiation.
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Therefore a trophoblast stem (TS) cell is the most appropriate cell
culture model. TS cells possess the capacity to proliferate and to
differentiate into mature trophoblast cell lineages and are ideal
models for investigating mechanisms underlying trophoblast cell
development [14–16].
Genes implicated in the regulation of placentation exhibit
conservation in their expression patterns and actions [17–22]. The
mouse has been an exceptional animal model for elucidating the
regulation of most aspects of hemochorial placentation [21, 23].
However, the mouse and human exhibit fundamental differences
in the extent of intrauterine trophoblast cell invasion and uterine
spiral artery remodeling. In the mouse, the depth of trophoblast
cell invasion is limited, whereas in the human the process is robust [8, 24, 25]. Organization of rat and human placentation sites
show significant conservation, especially regarding trophoblast
cell-directed remodeling of the uterine spiral arteries [24, 26–39].
Both species exhibit deep trophoblast invasion. The rat has many
of the advantages of the mouse, including the capacity for genetic
manipulation [40]. We have established relevant in vitro and in vivo
research methods using the rat as an animal model to investigate
molecular mechanisms regulating trophoblast cell differentiation
and invasion [24, 35–39, 41–48]. Blastocyst-derived rat TS cells
and Rcho-1 TS cells have proven to be effective in vitro culture
systems for elucidating regulatory pathways controlling trophoblast
cell differentiation [41, 44].
Several “candidate” signaling pathways have been implicated
in regulating differentiation of the invasive trophoblast cell lineage [21, 49]; however, the significance of most of these pathways
during in vivo placentation is unknown. In this short review, we
focus on two pathways as probes into the control of the invasive
trophoblast cell lineage: i] hypoxia/hypoxia inducible factor (HIF);
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and ii] phosphatidylinositol 3-kinase (PI3K)/AKT/FOS like antigen
1 (FOSL1). We have established the importance of these pathways
using both in vitro and in vivo experimentation [38, 43, 50–52].

Hypoxia/HIF Signaling Pathway
Oxygenation is critical to tissue morphogenesis. Oxygen deficits
can stimulate vascular development, tissue nutrition and growth,
and promote cellular specialization. This is also true for placental
morphogenesis. Oxygen tensions tend to be lower during early pregnancy and increase following the establishment of the hemochorial
placenta [53–59]. Low oxygen tension (hypoxia) is a physiological
regulator of hemochorial placentation, especially for in vivo development of the invasive trophoblast cell lineage. This in vivo response
to low oxygen is conserved in rodent and primate placentation [38,
60, 61]. Insights about the role of hypoxia as an intrinsic regulator
of placentation have been derived from mutagenesis of genes in
the mouse genome controlling cellular responses to O2 deprivation [56]. Central to the cellular response to hypoxia is the HIF
transcription factor complex [62–64]. Phenotypes of placentas with
null mutations for several genes encoding components of the HIF
signaling pathway, including HIF1A, HIF2A, HIF1B (dimerization
partner for HIF1A and HIF2A), prolyl hydroxylase domain protein
2, and von Hippel-Lindau genes, are associated with failures in
placentation [65–69]. Through in vivo experiments with Holtzman
Sprague-Dawley rats and in vitro experiments with rat TS cells [44],
our laboratory has demonstrated that development of the invasive
trophoblast cell lineage is activated by hypoxia [38, 52; Fig. 1].
In vivo exposure of pregnant rats to hypoxia (~11% oxygen) from
gestation day 6.5 to day 13.5 resulted in an expansion of blood vessel density and volume in the uterine mesometrial compartment,
a profound increase in the depth of endovascular trophoblast cell
invasion, and a reallocation of trophoblast cells within key compartments of the placenta [38]. Rat and mouse chorioallantoic placentas
are composed of two compartments (junctional zone and labyrinth
zone) associated with essential functions. The junctional zone is
situated at the interface with the uterine decidua, produces hormones
that modulate the maternal environment, and is the origin of the
invasive trophoblast cell population, whereas the labyrinth zone is
located at the fetal interface and contributes to bi-directional nutrient/waste transport between maternal and fetal vascular systems.
Maternal hypoxia leads to a preferential expansion of the junctional
zone, which is observed in both the rat and mouse [38, P. Bu and
M.J. Soares, unpublished results]. Responsiveness to hypoxia is
most evident during a critical window of pregnancy (gestation day
8.5 to day 9.5) when essential trophoblast cell lineage decisions
are being made [38].
In vitro rat TS cells respond to low oxygen tension (~0.5%)
by altering their differentiation state [52]. Hypoxia activates an
epithelial-mesenchymal-like transformation that is associated with
a decrease in the expression of E-cadherin (Cdh1) and increases in
the expression of matrix metalloproteinase 9 (Mmp9) and matrix
metalloproteinase 12 (Mmp12) and movement through an extracellular matrix (Matrigel; 53). These responses are dependent on
activation of the HIF signaling pathway [52].
In summary, there is a plasticity associated with placentation,

which is influenced by hypoxia [38, 52, 70]. TS cells are labile and
can differentiate in order to meet challenges within the maternal
environment (Fig. 1). Their differentiation is sensitive to oxygen
tension and dependent on HIF signaling [38, 52].

PI3K/AKT/FOSL1 Signaling Pathway
A signaling pathway involving PI3K/AKT/FOSL1 controls the
differentiation of the invasive trophoblast cell lineage and the trophoblast cell-directed uterine spiral artery remodeling phenotype
[43, 50, 51]. This has been determined through in vitro experiments
with Rcho-1 TS cells and in vivo experimentation with the Holtzman
Sprague-Dawley rat [51].
The PI3K/AKT pathway is a regulator of invasive trophoblast cells
[43, 51, 71–73]. Disruption of PI3K or AKT inhibits the expression
of genes associated with the invasive phenotype and trophoblast
cell invasion through an extracellular matrix [51]. These actions
are mediated, at least in part, through promoting the nuclear accumulation of FOSL1 protein [51]. FOSL1 is a basic region-leucine
zipper transcription factor and a contributor to the formation of
the activator protein-1 (AP-1) transcription factor complex [74].
In rat and human placentation sites, FOSL1 is expressed in the
extravillous/invasive trophoblast cell population [51, 75]. Fosl1
is also expressed in Rcho-1 TS cells induced to differentiate [43,
51]. FOSL1 knockdown in Rcho-1 TS cells inhibits the expression
of genes associated with the invasive trophoblast cell phenotype,
including carcinoembryonic antigen family 4 (Cgm4), interleukin 17f (Il17f ), Mmp9, prolactin family 4-subfamily a-member
1 (Prl4a1), and semaphorin 6D (Sema6d) [51; Kubota, Kent and
Soares unpublished results]. FOSL1 occupies regions of the Mmp9
promoter in trophoblast cells critical for the regulation of Mmp9
gene expression [51]. Inhibition of FOSL1 expression significantly
decreases Rcho-1 trophoblast cell invasion as assessed in vitro
through Matrigel-coated filters [51]. The in vivo involvement of
FOSL1 in regulating trophoblast cell invasion was also assessed
following trophectoderm-specific lentiviral shRNA delivery [45,
51]. FOSL1 knockdown inhibited endovascular trophoblast cell
invasion [51]. These FOSL1 actions in trophoblast cells are consistent with its prominent role in regulating invasion in other cell
types [76–79]. FOSL1 is also implicated as a potential regulator of
human trophoblast cells. Highly invasive trophoblast cells (HTR-8/
SVneo, Swan71) express higher levels of FOSL1 versus trophoblast
cells with limited invasiveness (BeWo, JEG3) (Renaud, Kubota,
Rumi and Soares, unpublished results). A key role for FOSL1 in
hemochorial placentation has also been derived from mice possessing a null mutation at the Fosl1 locus [80].
The actions of FOSL1 are dependent upon its interactions with
other proteins, especially members of the basic region-leucine zipper
transcription factor family (e.g. JUN, JUNB, and JUND; 75). In
preliminary experiments, we have observed that FOSL1 interacts
with JUN and JUNB in rat trophoblast cells (Rumi, Kubota, and
Soares, unpublished results). Based on expression and activity in
differentiating TS cells, JUNB is a strong candidate for serving
as a partner for FOSL1 [43, 81]. JUNB is also expressed in human
extravillous trophoblast cells [75]. Additionally, Junb null mutations phenocopy Fosl1 null mutations, both resulting in defective
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Hypoxia signaling and activation of the invasive trophoblast cell lineage and trophoblast cell-directed
uterine spiral artery remodeling. Panel A) Effects of maternal hypoxia on placentation. Exposure to
maternal hypoxia increases uterine vascularity, endovascular invasive trophoblast cell invasion,
and cellular allocation to the junctional zone of the chorioallantoic placenta. Panel B) Schematic
representation of the effects of oxygen tension on TS cells and HIF-dependent trophoblast cell lineage
decisions.

mouse placental development [80, 82].
Collectively, the data indicate that FOSL1 is a key downstream
effector of the PI3K/AKT signaling pathway responsible for development of invasive trophoblast cell lineages integral to establishing
the maternal-fetal interface (Fig. 2).

Overview
Our understanding of mechanisms regulating the invasive
trophoblast cell lineage is minimal. It is now evident that the processes of trophoblast cell invasion and trophoblast cell-directed
uterine spiral artery remodeling are conserved in model organisms, especially the rat. Technological advances have created an
unprecedented opportunity to make major progress in elucidating
regulatory mechanisms controlling development of the invasive
trophoblast cell lineage. With these new tools we have determined
that hypoxia/HIF and the PI3K/AKT/FOSL1 signaling pathways
participate in the control of the invasive trophoblast cell lineage.
It is expected that further dissection of these pathways will lead
to the identification of fundamental regulators of differentiation
and function of the invasive trophoblast cell lineage.

Fig. 2.

PI3K/AKT/FOSL1 pathway regulating the invasive trophoblast
cell lineage and trophoblast cell-directed uterine spiral artery
remodeling. Disruptions in the PI3K/AKT/FOSL1 pathway
leads to pregnancy related disease, including early pregnancy
loss, preeclampsia, pre-term birth, and intrauterine growth
restriction (IUGR).
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